To include your compound in the COVID-19 Resource Center, submit it here.

Bloody Tuesday for biotech

Biotech shares dropped in the wake of Monday's news of price wars for HCV drugs, with the BioCentury 100 index falling 5% and the NYSE Arca Biotechnology (BTK) dropping 4%.

The BioCentury benchmark has fallen 6% since last Friday. The BTK, which hit a 52-week high last Friday, is off 5% on

Read the full 520 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers